We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against other non-tech AI ...

(Reuters) - Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling subdued demand for its genetic tests and diagnostic tools ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

The Illumina MiSeq i100 Series, announced last fall, is the company's first customer-installable instrument since the iSeq. Illumina's latest offering was a brand-new challenge for Staff Software ...

Illumina recently launched the MiSeq i100 and ... For a project like the MiSeq i100, a hardware team begins building what they call the "prototype one," or P1, instruments and consumables.